Lemonade Inc (NYSE:LMND) currently has a daily average trading volume of 2.13M but it saw 2465947 shares traded in last market. With a market cap of 3.14B USD, the company’s current market price of $42.8 came rising about 4.14 while comparing to the previous closing price of $41.1. In past 52 weeks, the stock remained buoying in the range of price level as high as $53.85 and as low as $14.90. In the recent trading on the day, stock has struck highest price mark of $40.75 while lowest mark touched by it was $43.18.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which downgraded the stock as “Underweight” in its note to investors issued on April 08, 2025, recommending a price target of $24 for it. Morgan Stanley upgraded its recommendation for the stock as a “Equal-Weight” from “Underweight” on November 20, 2024 while assigning a price target range of $23-$42. Keefe Bruyette also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $18 and $21.
Over the week, LMND’s stock price is moving 5.68% up while it is 29.23% when we observe its performance for the past one month. Year-to-date it is 169.18% up and over the past year, the stock is showing an upside performance of 16.68%.
The company is expected to be releasing its next quarterly report on 2025-May-06, for which analysts forecasted an EPS of -0.77 while estimate for next year EPS is -2.85. In next quarter, company is expected to be making quarterly sales of $173.26M as analysts are expecting the sales for current fiscal year at $669.08M and seeing the company making $875.12M in sales next year. Moreover, analysts are in estimates of $161.46M for current-quarter revenue.
Currently, Lemonade Inc’s total number of outstanding shares is 73.21M with 24.66% of that held by the insiders while 46.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -38.30% and return on equity (ROE) at -35.57%. Stock’s beta reads 2.17. Stock has a price to book (P/B) ratio of 5.74 while price to sale or P/S ratio amounts to 6.79. Its return on asset (ROA) is -16.20% on average.
